1 results  1 of 1 

1 Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
Yoon Kyung Park, Kang Mo Kim, Young-Joo Lee, Ki-Hun Kim, Sung-Gyu Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
J Korean Med Sci.2011;26(2):214-221.   Published online 2011 January 24     DOI: http://dx.doi.org/10.3346/jkms.2011.26.2.214
      

 1 of 1